Media Pack
News

Current Edition

Volume 16 Issue 2
 
Volume 14 Issue 6

Recent FDA Advancements in Rare Diseases – Funding, Partnerships, and Programs

The paucity of therapeutic choices is a reality often acknowledged by the US Food and Drug Administration (FDA) as it reviews applications for new medical products or...
30 November 2022 Volume 14 Issue 6 applications | approved
Continue Reading →
Volume 14 Issue 6

Learning From The Past

How Sharing Clinical Science Research During the Pandemic has better Prepared Us for The Future “The scientific community working together can do some pretty amazing...
30 November 2022 Volume 14 Issue 6 approved | conclusion
Continue Reading →
Europe

TiGenix and Takeda announce Alofisel® (darvadstrocel) receives approval to treat complex perianal fistulas in Crohn’s disease in Europe

  First allogeneic stem cell therapy to receive central marketing authorization approval in Europe Alofisel offers a new treatment option for patients who d...
28 March 2018 Europe Alofisel | approved
Continue Reading →
 

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2024, All Rights Reserved – Powered by Teksyte